China Pharma Holdings income decreases 7 kamagra yelly .4 percent to $5.7 million in Q2 2015 China Pharma Holdings, Inc. , an NYSE MKT outlined corporation using its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced monetary results for the one fourth ended June 30, 2015. Second One fourth Highlights Revenue reduced 7.4 percent to $5.7 million in the second quarter of 2015 from $6.1 million in the second quarter of 2014. Gross loss was million in the second quarter of 2015, in comparison to gross profit of $2.4 million in the second quarter of 2014. Loss from operations was $3.8 million in the second quarter of 2015 compared to $8.5 million in the next quarter of 2014. Net loss was $4.1 million in the next quarter of 2015 compared to $8.6 million in the next quarter of 2014.
Products aren’t safe. In the most recent case, the official Xinhua News Company reported Tuesday a shipment of sugar-free drink mix from the United States have been rejected for having an excessive amount of red dye.. China Executes Ex-Food & Drug Watchdog China executed the former head of its meals and drug watchdog on Tuesday for approving untested medicine in exchange for cash, the strongest signal yet from Beijing that it is seriously interested in tackling its product basic safety crisis. During Zheng Xiaoyu’s tenure from 1998 to 2005, the State Meals and Medication Administration approved six medicines that turned out to be fake, and the drug-makers used falsified papers to apply for approvals, relating to earlier state media reviews.